Drug-induced eosinophilia and systemic symptoms: hypersensitivity or peripheral T-cell lymphoma? [1]

Archives of Dermatology

Volumn 141, Issue 3, 2005, Pages 395-396

  Schleinitz, Nicolas ^a   Veit, Véronique ^b   Coso, Diane ^b   Aurran, Thérèse ^b   Berbis, Philippe ^b   Harle, Jean Robert ^a  

^a HÔPITAL DE LA CONCEPTION   (France)

^b CHU Conception ^*

Author keywords

[No Author keywords available]

Indexed keywords

DICLOFENAC; PREDNISONE;

ADULT; CASE REPORT; CLINICAL FEATURE; DRUG DOSE REDUCTION; DRUG DOSE REGIMEN; DRUG ERUPTION; DRUG HYPERSENSITIVITY; DRUG INDUCED DISEASE; EOSINOPHILIA; FEMALE; HUMAN; LETTER; LYMPH NODE BIOPSY; PERIPHERAL T CELL LYMPHOMA; PRIORITY JOURNAL;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BIOPSY, NEEDLE; CYCLOPHOSPHAMIDE; DIAGNOSIS, DIFFERENTIAL; DICLOFENAC; DOXORUBICIN; DRUG HYPERSENSITIVITY; ERYTHEMA; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; LOW BACK PAIN; LYMPHOMA, T-CELL, PERIPHERAL; PREDNISOLONE; RISK ASSESSMENT; TREATMENT OUTCOME; VINCRISTINE;

EID: 14944363331     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archderm.141.3.395     Document Type: Letter

References (4)

1. Bocquet H, Bagot M, Roujeau JC. Drug-induced pseudolymphoma and drug hypersensitivity syndrome (drug rash with eosinophilia and systemic symptoms: DRESS). Semin Cutan Med Surg. 1996;15:250-257.
2. Tas S, Simonart T. Management of drug rash with eosinophilia and systemic symptoms (DRESS syndrome): an update. Dermatology. 2003;206:353-356.
3. Martel P, Laroche L, Courville P, et al. Cutaneous involvement in patients with angioimmunoblastic lymphadenopathy with dysproteinemia. Arch Dermatol. 2000;136:881-886.
4. Pautier P, Devidas A, Delmer A, et al. Angioimmunoblastic-like T-cell non Hodgkin's lymphoma: outcome after chemotherapy in 33 patients and review of the literature. Leuk Lymphoma. 1999;32:545-552.